8DE634A7-9A24-4FB0-9A84-2320C77E2FE9Proximity to Discovery - University of OxfordIntramuralMC_PC_14131C008C651-F5B0-4859-A334-5F574AB6B57CMRCEXPENDITURE_ACTUAL150000AC6FA474-FE27-4FAB-92E9-A052B6C93169Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function.The Journal of allergy and clinical immunology9ca174d7cdc7d1c82054fcfe145a9b2aHardman C2019-01-01http://dx.doi.org/10.1016/j.jaci.2019.02.01530825466http://ukpmc.ac.uk/abstract/MED/308254660091-6749http://europepmc.org/abstract/MED/308254661436Journal Article/Review5e4286e3c08e35.87799129